World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
47
Citations
9251
World Ranking
4506
National Ranking
2037

Charles H. Hoke publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Charles H. Hoke sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 84 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Charles H. Hoke D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Charles H. Hoke sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 47 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Charles H. Hoke is affiliated with the Walter Reed Army Institute of Research, a prominent biomedical research facility in the United States. The association with this institution situates their work within a context focused on military medical research and related scientific inquiries.

The available information does not list specific publications authored by Charles H. Hoke. Consequently, details such as paper titles, years of publication, and venues are not provided, which limits insight into recent contributions to scientific literature.

There are no recorded frequent co-authors connected to Charles H. Hoke. Similarly, no data is available regarding regular publication venues, which means there is no indication of recurring journals or conferences in which this scientist publishes.

Information about book publications is also absent, so it is not known whether Charles H. Hoke has authored or contributed to academic books or monographs available through recognized publishers.

The data does not specify primary fields of study, subfields, or main research topics linked to this scientist. This lack of detailed topic metadata prevents an assessment of the particular scientific domains or specialties they may focus on.

No awards or honors have been recorded in this dataset for Charles H. Hoke, and the scientist is not noted as deceased. The absence of such information may indicate either a lack of publicly known accolades or that this data has not been documented here.

Best Publications

  • Estimated global incidence of Japanese encephalitis: a systematic review

    Grant L Campbell;Susan L Hills;Marc Fischer;Julie A Jacobson

  • An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate.

    B. L. Innis;A. Nisalak;S. Nimmannitya;S. Kusalerdchariya

  • Protection against Japanese Encephalitis by Inactivated Vaccines

    C H Hoke;A Nisalak;N Sangawhipa;S Jatanasen

  • SEROTYPE-SPECIFIC DENGUE VIRUS CIRCULATION AND DENGUE DISEASE IN BANGKOK, THAILAND FROM 1973 TO 1999

    Ananda Nisalak;Timothy P. Endy;Suchitra Nimmannitya;Siripen Kalayanarooj

  • Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

    N. Kanesa-thasan;W. Sun;G. Kim-Ahn;S. Van Albert

  • Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases.

    Richard T. Johnson;Donald S. Burke;Michael Elwell;Colin J. Leake

  • Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates.

    Hideo Sumiyoshi;Charles H. Hoke;Dennis W. Trent

  • Sensitivity and specificity of a universal primer set for the rapid diagnosis of dengue virus infections by polymerase chain reaction and nucleic acid hybridization.

    Erik A. Henchal;Stephanie L. Polo;Vance Vorndam;Chandhana Yaemsiri

  • Effect of High-Dose Dexamethasone on the Outcome of Acute Encephalitis Due to Japanese Encephalitis Virus

    Charles H. Hoke;David W. Vaughn;Ananda Nisalak;Pensri Intralawan

  • Development of a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype in Vero Cells: Immunogenicity and Protection in Mice and Rhesus Monkeys

    Robert Putnak;David A. Barvir;Jeanne M. Burrous;Doria R. Dubois

  • Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production.

    Ichiro Kurane;Bruce L. Innis;Ananda Nisalak;Charles H. Hoke

  • Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates.

    Wellington Sun;Robert Edelman;Niranjan Kanesa-Thasan;Kenneth H. Eckels

  • Fatal outcome in Japanese encephalitis.

    Donald S. Burke;Wanida Lorsomrudee;Colin J. Leake;Charles H. Hoke

  • Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers

    David W. Vaughn;Charles H. Hoke;Sutee Yoksan;Rebecca LaChance

  • Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein.

    P. W. Mason;J. M. Dalrymple;M. K. Gentry;J. M. McCown

  • Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans.

    Niranjan Kanesa-thasan;John J. Smucny;Charles H. Hoke;Donald H. Marks

  • Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection

    Ashok Kumar Srivastava;Joseph Robert Putnak;Richard Lloyd Warren;Charles Hearn Hoke

  • Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers

    W. H. Bancroft;R. M. Scott;K. H. Eckels;C. H. Hoke

  • A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans.

    Robert Edelman;Carol O. Tacket;Steven S. Wasserman;David W. Vaughn

  • History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system.

    Charles H. Hoke;Clifford E. Snyder

  • Infection of Owl Monkeys (Aotus trivirgatus) and Cynomolgus Monkeys (Macaca fascicularist) with Hepatitis E Virus from Mexico

    John Ticehurst;John Ticehurst;John Ticehurst;Lowrey L. Rhodes;Krzysztof Krawczynski;Krzysztof Krawczynski;Krzysztof Krawczynski;Ludmila V.S. Asher;Ludmila V.S. Asher;Ludmila V.S. Asher

Frequent Co-Authors

Bruce L. Innis
Bruce L. Innis GlaxoSmithKline (United Kingdom)
David W. Vaughn
David W. Vaughn Bill & Melinda Gates Foundation
Ananda Nisalak
Ananda Nisalak United States Department of the Army
Donald S. Burke
Donald S. Burke University of Pittsburgh
Kenneth H. Eckels
Kenneth H. Eckels Walter Reed Army Institute of Research
Ichiro Kurane
Ichiro Kurane National Institutes of Health
Francis A. Ennis
Francis A. Ennis University of Massachusetts Chan Medical School
Robert R. Edelman
Robert R. Edelman Northwestern University
Anthony A. Marfin
Anthony A. Marfin A2M Epidemiology
Richard T. Johnson
Richard T. Johnson Johns Hopkins University School of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related nursing degrees such as Nurse Practitioner (NP) programs can open diverse healthcare career opportunities. If you’re seeking a program with less intensive requirements, exploring what is the easiest np program can provide insights into more accessible pathways to advanced practice nursing roles.

Psychiatric Mental Health Nurse Practitioner (PMHNP) programs are particularly relevant for professionals aiming to specialize in mental health and immunological impacts on psychiatric conditions. The top online pmhnp programs offer strong clinical placement rates, ensuring valuable hands-on experience crucial for career success.

Affordability is another important factor when choosing an online degree. Prospective students should consider the cheapest psych np programs to balance quality education with financial feasibility, especially when planning long-term career paths in immunology-adjacent healthcare fields.

Understanding compensation after degree completion is essential. Salary transparency, such as available through resources detailing the dnp salary transparency, helps graduates make informed decisions about their investment in advanced practice degrees and potential earnings in different states.

Best Scientists Citing Charles H. Hoke

Recently Published Articles